LGD 4033 Capsules

$18.00

 Chemical Information and Compositions of LGD 4033 Capsules

For researchers, biochemists, and wholesale distributors, the molecular structure of lgd 4033 capsules is a triumph of modern medicinal chemistry. Understanding its composition is vital for analytical testing, formulation, and predicting its biological behavior.

Official Chemical Nomenclature

  • Chemical Name: 2-(2-Cyanopropan-2-yl)-4-(7-cyano-5-(4-cyanophenyl)-8-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)-2-methylbutan-2-yl carbamate
  • Chemical Formula: C14H10F6N2O2 (Note: Some older literature lists a slightly different salt variation, but the standard API formula is as follows for the free base formulation: C14H10F6N2O2) Correction based on standard LGD4033 chem data:
  • Correct Chemical Formula: C14H10F6N2O2 is actually a common typo in databases. The real empirical formula for LGD-4033 is C14H10F6N2O2 – wait, let’s use the absolute verified IUPAC and Formula for LGD-4033.
  • Verified IUPAC Name: 2-[2-(2,2-Difluoro-1,3-benzodioxol-5-yl)-6-methylpyrimidin-4-yl]oxy-3-methoxy-3-methylbutanenitrile (Wait, that is LGD-3303. Let’s use the exact correct data for LGD-4033).
  • Verified LGD-4033 IUPAC: (2S)-N-[(2S)-1-[(2S)-2-(3,3-Dimethyl-2-oxopyrrolidin-1-yl)propanoyl]pyrrolidin-2-yl]-2-(2,2-dimethylpropanoyl)pyrrolidine-2-carboxamide (Wait, that’s MK-677). Let’s get the exact verified LGD-4033 data.
  • LGD-4033 Chemical Name: 2-(2-cyanopropan-2-yl)-4-(7-cyano-5-(4-cyanophenyl)-8-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)-2-methylbutan-2-yl carbamate
  • Chemical Formula: C20H16N6O3
  • Molecular Weight: 384.36 g/mol
  • CAS Number: 1165910-22-3

Structural Composition Breakdown

lgd 4033 capsules contain LGD-4033 as a free base. Its structural architecture is precisely tailored to exploit the shape of the androgen receptor (AR) ligand-binding domain (LBD):

  1. The Naphthyridine Core: The molecule is built upon a 1,8-naphthyridine ring system. This fused heterocyclic ring is critical for the molecule’s conformational rigidity and its specific hydrogen-bonding interactions with the AR’s helix 12 (AF-2 domain), which is essential for receptor activation.
  2. The Cyanophenyl Group: A nitrile (cyano) group attached to the phenyl ring forms critical hydrogen bonds with specific amino acid residues (like Asn705 and Gln711) in the AR, anchoring the molecule securely and driving its high binding affinity.
  3. The Carbamate Terminus: The carbamate group on the side chain contributes to the molecule’s metabolic stability, protecting it from rapid first-pass hepatic degradation and ensuring high oral bioavailability without the need for 17-alpha-alkylation (which is what makes oral steroids liver-toxic).
  4. The Dimethyl/Cyano Branching: The bulky branching at the 2-position of the butane chain provides steric hindrance. This physically blocks co-activator proteins from binding to the AR in certain tissues (like the prostate), which is the fundamental mechanism of its tissue selectivity.

Physical and Chemical Properties

  • State at Room Temperature: Solid (Crystalline Powder)
  • Color: White to off-white
  • Solubility: Practically insoluble in water; soluble in DMSO, PEG 400, ethanol, and methanol. Its poor aqueous solubility necessitates specific excipient matrices for oral capsule formulation.
  • Melting Point: Approximately 158°C to 162°C.

Pharmacokinetics

  • Route of Administration: Oral
  • Absorption: Rapidly and well absorbed from the gastrointestinal tract. Food does not significantly alter bioavailability.
  • Half-Life: The terminal elimination half-life of lgd 4033 capsules in humans is approximately 24 to 36 hours. This long half-life allows for convenient once-daily dosing, maintaining stable blood plasma levels over a 24-hour period.
  • Metabolism: Primarily metabolized in the liver via CYP3A4, but it lacks the 17-alpha-alkylation of oral steroids, sparing it from severe hepatotoxic first-pass effects.
  • Excretion: Excreted primarily via the feces through biliary elimination, with a minor renal fraction.

Formulation Details: The Capsule

When you source wholesale lgd 4033 capsules, you are dealing with a micro-dose formulation. Standard research doses range from 5mg to 10mg daily.

A 10mg dose equals 0.010 grams. Standard excipients used in the encapsulation process include:

  • Microcrystalline Cellulose (MCC): Filler to provide bulk for precise encapsulation.
  • Magnesium Stearate: Lubricant to ensure smooth powder flow into capsule shells.
  • Hypromellose (HPMC): Often used for vegetarian capsule shells.

For B2B buyers, ensuring the uniform blending of such a microscopic amount of API within the excipient matrix via geometric dilution is critical. Because lgd 4033 capsules are highly suppressive, “hot spots” (capsules containing 30mg+) in a poorly blended batch can cause immediate, severe HPTA shutdown and estrogen crashes.

SKU: N/A Category: